These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2549498

  • 1. Humoral immunity and clinical reinfections following varicella vaccine in healthy children.
    Johnson C, Rome LP, Stancin T, Kumar ML.
    Pediatrics; 1989 Sep; 84(3):418-21. PubMed ID: 2549498
    [Abstract] [Full Text] [Related]

  • 2. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE, Shurin PA, Fattlar D, Rome LP, Kumar ML.
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [Abstract] [Full Text] [Related]

  • 3. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I, Study Group for Varivax.
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [Abstract] [Full Text] [Related]

  • 4. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y, Nagai T, Miyata T, Yazaki T, Ito S, Yamanishi K, Takahashi M.
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [Abstract] [Full Text] [Related]

  • 5. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y, Albrecht P, Vujcic LK, Quinnan GV, Kawakami K, Takahashi M.
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [Abstract] [Full Text] [Related]

  • 6. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, Connor KA, McLean AA, Hilleman MR, Buynak EB.
    N Engl J Med; 1984 May 31; 310(22):1409-15. PubMed ID: 6325909
    [Abstract] [Full Text] [Related]

  • 7. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children.
    Asano Y, Takahashi M.
    Pediatrics; 1977 Dec 31; 60(6):810-4. PubMed ID: 202916
    [Abstract] [Full Text] [Related]

  • 8. A live varicella vaccine in a pediatric community.
    Yabuuchi H, Baba K, Tsuda N, Okada S, Nose O, Seino Y, Tomita K, Ha K, Mimaki T, Ogawa M.
    Biken J; 1984 Sep 31; 27(2-3):43-9. PubMed ID: 6100057
    [Abstract] [Full Text] [Related]

  • 9. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine.
    Watson BM, Piercy SA, Plotkin SA, Starr SE.
    Pediatrics; 1993 Jan 31; 91(1):17-22. PubMed ID: 8416499
    [Abstract] [Full Text] [Related]

  • 10. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
    Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, Chartrand SA, Cho I, Ngai A, White CJ.
    Pediatrics; 1993 Dec 31; 92(6):833-7. PubMed ID: 8233746
    [Abstract] [Full Text] [Related]

  • 11. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA, Steinberg SP.
    N Engl J Med; 1989 Apr 06; 320(14):892-7. PubMed ID: 2538749
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL, Chan IS, Wang WW, Matthews H, Kuter BJ.
    Pediatr Infect Dis J; 2007 Jul 06; 26(7):572-6. PubMed ID: 17596796
    [Abstract] [Full Text] [Related]

  • 13. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
    Ueda K, Tokugawa K, Nakashima F, Takahashi M.
    Biken J; 1984 Sep 06; 27(2-3):119-22. PubMed ID: 6100048
    [Abstract] [Full Text] [Related]

  • 14. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989.
    White CJ, Kuter BJ, Hildebrand CS, Isganitis KL, Matthews H, Miller WJ, Provost PJ, Ellis RW, Gerety RJ, Calandra GB.
    Pediatrics; 1991 May 06; 87(5):604-10. PubMed ID: 1850506
    [Abstract] [Full Text] [Related]

  • 15. Vaccination of children with malignant disease against varicella.
    Slørdahl SH, Wiger D, Strømøy T, Degre M, Thørsby E, Lie SO.
    Postgrad Med J; 1985 May 06; 61 Suppl 4():85-92. PubMed ID: 3014484
    [Abstract] [Full Text] [Related]

  • 16. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M, Kamiya H, Baba K, Asano Y, Ozaki T, Horiuchi K.
    Postgrad Med J; 1985 May 06; 61 Suppl 4():61-7. PubMed ID: 3014479
    [Abstract] [Full Text] [Related]

  • 17. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M, Boudailliez B.
    Postgrad Med J; 1985 May 06; 61 Suppl 4():103-6. PubMed ID: 3014466
    [Abstract] [Full Text] [Related]

  • 18. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A.
    Clin Infect Dis; 2002 Mar 15; 34(6):774-9. PubMed ID: 11830801
    [Abstract] [Full Text] [Related]

  • 19. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
    Austgulen R.
    Postgrad Med J; 1985 Mar 15; 61 Suppl 4():93-5. PubMed ID: 3014485
    [Abstract] [Full Text] [Related]

  • 20. Live attenuated varicella vaccine: the KMcC strain in healthy children.
    Arbeter AM, Starr SE, Weibel RE, Neff BJ, Plotkin SA.
    Pediatrics; 1983 Mar 15; 71(3):307-12. PubMed ID: 6298698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.